Manuel Monréal
Manuel Monréal publishes mostly in Internal Medicine, Cardiology and Cardiovascular Medicine and Surgery, on topics such as Venous Thromboembolism Diagnosis and Management, Atrial Fibrillation Management and Outcomes and Blood Coagulation and Thrombosis Mechanisms.
- World rank
- #94,751 of 7,710,434 ranked researchers
- Rank in Spain
- #1,220 of 204,306
- Works
- 704
- Citations
- 33k
- Citations per work
- 46.9
What does Manuel Monréal research?
Manuel Monréal's work is mostly in Medicine (76%), Health Professions (4%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences56880.7%
- Medicine53976.5%
- Health Professions304.2%
- Everything else13619.3%
- 1Internal Medicine31% of their works
- 2Cardiology and Cardiovascular Medicine22% of their works
- 3Surgery11% of their works
- 4Hematology7% of their works
- 5Epidemiology5% of their works
- 6Emergency Medical Services4% of their works
Research topics
- Venous Thromboembolism Diagnosis and Management
- Atrial Fibrillation Management and Outcomes
- Blood Coagulation and Thrombosis Mechanisms
- Heparin-Induced Thrombocytopenia and Thrombosis
- Central Venous Catheters and Hemodialysis
- Acute Myocardial Infarction Research
- Acute Ischemic Stroke Management
- Diagnosis and Treatment of Venous Diseases
Which keywords describe Manuel Monréal's research?
The keywords of their largest research topics: Antithrombotic Therapy, Diagnosis, Risk Factors, Clinical Practice Guidelines, Pulmonary Embolism, Venous Thromboembolism, Guidelines and Anticoagulant Therapy.
- Chronic Venous Insufficiency
- Ischemic Stroke
- Acute Coronary Syndromes
- Catheter-Related Infections
- Heparin-Induced Thrombocytopenia
- Protease-Activated Receptors
- Anticoagulant Therapy
- Venous Thromboembolism
- Clinical Practice Guidelines
- Diagnosis
- Antithrombotic Therapy
- Risk Factors
- Pulmonary Embolism
- Guidelines
- Atrial Fibrillation
- Thrombin
- Thrombosis
- Central Venous Catheterization
- Myocardial Infarction
- Thrombolysis
- Varicose Veins
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 21 words, with their numbers
- Antithrombotic Therapy6962 topics
- Diagnosis6562 topics
- Risk Factors6332 topics
- Clinical Practice Guidelines6302 topics
- Pulmonary Embolism5771 topic
- Venous Thromboembolism5771 topic
- Guidelines2962 topics
- Anticoagulant Therapy2361 topic
- Atrial Fibrillation2361 topic
- Protease-Activated Receptors1191 topic
- Thrombin1191 topic
- Heparin-Induced Thrombocytopenia791 topic
- Thrombosis791 topic
- Catheter-Related Infections771 topic
- Central Venous Catheterization771 topic
- Acute Coronary Syndromes601 topic
- Myocardial Infarction601 topic
- Ischemic Stroke561 topic
- Thrombolysis561 topic
- Chronic Venous Insufficiency531 topic
- Varicose Veins531 topic
Where does Manuel Monréal work?
Manuel Monréal's main affiliation in the publication record is Hospital Universitari Germans Trias i Pujol, Spain.
How many publications and citations does Manuel Monréal have?
OpenAlex counts 704 works and 33,000 citations for Manuel Monréal, an h-index of 79, ranking #94,751 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Other researchers named Manuel Monréal
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Manuel Monréal. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.